Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
861.50
Change Change %
7.75 0.91%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
860.05
Change Change %
7.45 0.87%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Credit Suisse
N/A
24-09-2015 Buy 1921.30 2250.00
N/A
Closed Custom
24-09-2016

Credit Suisse Upgrades Lupin to Outperform

Credit Suisse has upgraded Lupin to 'outperform' for target price of Rs 2,250 per share. Credit Suisse says that Fortamet's price increase is sustainable and upside potential from diabetes drugs is not priced in yet. Credit Suisse adds that FDA overhang on Goa facility has reduced and it has increased FY17/18 estimated EPS for Lupin by 18 per cent.

Top